Proposed LCD DL40197: MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis — Noridian
Policy LCD-DL40197 · Gastroenterology
Impact on billing for liver disease biomarker testing.